Abiopharma

🔍 Shepro William B (Executive)

Company: ALTISOURCE PORTFOLIO SOLUTIONS S.A. (ASPS)

Report Date: 2026-07-28

Detailed Transactions and Holdings:

• Acquired 4,000 shares of Common Stock at $5.18 per share (Direct)
  Date: 2026-07-28 | Code: P | equity_swap_involved: false | shares_owned_after: 8,686.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-28 | Code: H | nature_of_ownership: The William B. Shepro Revocable Trust | shares_owned_after: 232,064.00
• Holds 9,400 shares of Net Settle Stakeholder Warrants (Right to Buy) at $1.95 per share (Derivative)
  Date: 2026-07-28 | Code: H | Expires: 2032-04-30 | Exercise: 2025-07-25 | shares_owned_after: 9,400.00 | Footnotes: F2
• Holds 9,400 shares of Cash Exercise Stakeholder Warrants (Right to Buy) at $1.95 per share (Derivative)
  Date: 2026-07-28 | Code: H | Expires: 2029-04-02 | Exercise: 2025-07-25 | shares_owned_after: 9,400.00 | Footnotes: F2
• Holds 2,253,673 shares of Cash Exercise Stakeholder Warrants (Right to Buy) at $1.95 per share (Derivative)
  Date: 2026-07-28 | Code: H | Expires: 2029-04-02 | Exercise: 2025-07-25 | shares_owned_after: 2,253,673.00
• Holds 2,253,673 shares of Net Settle Stakeholder Warrants (Right to Buy) at $1.95 per share (Derivative)
  Date: 2026-07-28 | Code: H | Expires: 2032-04-30 | Exercise: 2025-07-25 | shares_owned_after: 2,253,673.00

Footnotes:

• F1: The reported price represents a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $5.15 to $5.22 per share. Upon request by the SEC staff, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
• F2: The reporting person has determined that securities beneficially owned by the Gina H. Shepro Revocable Trust were previously reflected in the holdings reported through the William B. Shepro Revocable Trust. This Form 4 separately reports the holdings through each trust to reflect the reporting person's current understanding of the ownership structure. This clarification does not reflect a transaction or any change in the reporting person's aggregate beneficial ownership.